EU healthcare systems face growing threat from carbapenem-resistant Enterobacterales

Carbapenem-resistant Enterobacterales (CRE), including carbapenem-resistant Klebsiella pneumoniae and carbapenem-resistant Escherichia coli, pose a major risk to patients and healthcare systems in the EU/EEA.

Solera Health Expands HALO Platform to Tackle High-Cost Specialty Care with Virtual Specialists

What You Should Know: – Solera Health, a leading healthcare technology platform, today announced a significant expansion of its HALO Platform. This next-generation solution now

January 5, 2024

Sponsors urged to compensate oncology patients and meet trial staff face-to-face – Pharmaceutical Technology

Traditionally oncology patients have not been compensated for participating in clinical trials. Credit: Shutterstock / Kunlanan Yarist Sponsors are being urged to compensate participants in

October 24, 2023

Vertex strikes $4.9B deal for Alpine, expanding work in kidney and autoimmune disease

Reshma Kewalramani is putting Vertex’s $10 billion-plus balance sheet to work. On Wednesday, the biotech announced it would pay $4.9 billion for Alpine Immune Sciences

April 11, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.